Fig. 3. Predicted number of events avoided for ischaemic stroke, major coronary events, and intracerebral haemorrhage per 10,000 patients treated by lowering LDL-C by 1 mmol/L with statins for 5 years in Chinese adults with different levels of vascular risk.
The estimated number of events (and their standard deviations) avoided by lowering LDL-C by 1 mmol/L, obtained by applying the rate ratios from the LDL-C-lowering trials to low, medium and high-risk population subgroups in CKB, are shown below the figure.